Comparison of ATLG and ATG for Immune Reconstitution After Allo-HSCT for Hematologic Malignancy
Clinical trial NCT06895538 · RECRUITING
Trial details
- NCT number
- NCT06895538
- Sponsor
- Peking University First Hospital
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-03
- Primary completion
- 2027-02-28
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.